Compare H2O America (HTO) vs Sanofi SA (SNY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
H2O America vs Sanofi SA — how do they compare? H2O America trades at $63.79 (market cap $2.70B), while Sanofi SA trades at $44.05 (market cap $104.83B). The key difference: Sanofi SA is far larger — about 38.8× H2O America's market cap, and Sanofi SA pays the higher dividend (5.5%). Which is the better fit depends on your goals.
| HTO | SNY | |
|---|---|---|
Market Cap | $2.70B | $104.83B |
Sector | Technology | Health |
52-Week High | $65.43 | $52.34 |
52-Week Low | $44.44 | $41.33 |
Enterprise Value | $4.42B | $121.32B |
Dividend Yield | 2.73% | 5.5% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About H2O America
H2O America is a utility company that provides essential water and wastewater services, primarily in the United States. The company operates a network of regulated water and wastewater systems, focusing on responsible resource management and high-quality service delivery. HTO aims to expand its operational footprint through acquisitions and internal growth, serving residential, commercial, and industrial customers.
Read more on HTO →About Sanofi SA
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →
